BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ebrahimzadeh M, El Mansari M, Blier P. Synergistic effect of aripiprazole and escitalopram in increasing serotonin but not norepinephrine neurotransmission in the rat hippocampus. Neuropharmacology 2019;146:12-8. [DOI: 10.1016/j.neuropharm.2018.11.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Török B, Fodor A, Klausz B, Varga J, Zelena D. Ameliorating schizophrenia-like symptoms in vasopressin deficient male Brattleboro rat by chronic antipsychotic treatment. Eur J Pharmacol 2021;909:174383. [PMID: 34332923 DOI: 10.1016/j.ejphar.2021.174383] [Reference Citation Analysis]
2 García-Durán L, Flores-Burgess A, Cantero-García N, Puigcerver A, Narváez JÁ, Fuxe K, Santín L, Millón C, Díaz-Cabiale Z. Galanin(1-15) Potentiates the Antidepressant-like Effects Induced by Escitalopram in a Rat Model of Depression. Int J Mol Sci 2021;22:10848. [PMID: 34639188 DOI: 10.3390/ijms221910848] [Reference Citation Analysis]
3 El Mansari M, Ebrahimzadeh M, Hamati R, Iro CM, Farkas B, Kiss B, Adham N, Blier P. Long-term administration of cariprazine increases locus coeruleus noradrenergic neurons activity and serotonin1A receptor neurotransmission in the hippocampus. J Psychopharmacol 2020;34:1143-54. [PMID: 32684081 DOI: 10.1177/0269881120936891] [Reference Citation Analysis]
4 Hamati R, El Mansari M, Blier P. Serotonin-2B receptor antagonism increases the activity of dopamine and glutamate neurons in the presence of selective serotonin reuptake inhibition. Neuropsychopharmacology 2020;45:2098-105. [PMID: 32473594 DOI: 10.1038/s41386-020-0723-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Perez de la Mora M, Hernandez-Mondragon C, Crespo-Ramirez M, Rejon-Orantes J, Borroto-Escuela DO, Fuxe K. Conventional and Novel Pharmacological Approaches to Treat Dopamine-Related Disorders: Focus on Parkinson's Disease and Schizophrenia. Neuroscience 2020;439:301-18. [PMID: 31349007 DOI: 10.1016/j.neuroscience.2019.07.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]